Literature DB >> 27240732

Increased short- and long-term mortality in 8146 hospitalised peptic ulcer patients.

H Malmi1, H Kautiainen2,3, L J Virta4, M A Färkkilä5.   

Abstract

BACKGROUND: Incidence and complications of peptic ulcer disease (PUD) have declined, but mortality from peptic ulcer bleeding has remained unchanged. The few recent studies on mortality associated with both uncomplicated and complicated patients with peptic ulcer disease provide contradictory results. AIMS: To evaluate short- and long-term mortality, and the main causes of death in peptic ulcer disease.
METHODS: In this retrospective epidemiologic cohort study, register data on 8146 adult patients hospitalised with peptic ulcer disease during 2000-2008 were collected in the capital region of Finland. All were followed in the National Cause of Death Register until the end of 2009. The data were linked with the nationwide Drug Purchase Register of the Finnish Social Insurance Institution.
RESULTS: Mean follow-up time was 4.9 years. Overall mortality was substantially increased, standardised mortality ratio 2.53 (95% CI: 2.44-2.63); 3.7% died within 30 days, and 11.8% within 1 year. At 6 months, the survival of patients with perforated or bleeding ulcer was lower compared to those with uncomplicated ulcer; hazard ratios were 2.06 (1.68-2.04) and 1.32 (1.11-1.58), respectively. For perforated duodenal ulcers, both the short- and long-term survival was significantly impaired in women. The main causes of mortality at 1 year were malignancies and cardiovascular diseases. Previous use of statins was associated with significant reduction in all-cause mortality.
CONCLUSIONS: One-year mortality in patients hospitalised with peptic ulcer disease remained high with no change. This peptic ulcer disease cohort had a clearly decreased survival rate up to 10 years, especially among women with a perforated duodenal ulcer, most likely explained by poorer survival due to underlying comorbidity.
© 2016 John Wiley & Sons Ltd.

Entities:  

Mesh:

Year:  2016        PMID: 27240732     DOI: 10.1111/apt.13682

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  5 in total

Review 1.  [Duodenal ulcers, gastric ulcers and Helicobacter pylori].

Authors:  Peter Dovjak
Journal:  Z Gerontol Geriatr       Date:  2017-02-01       Impact factor: 1.281

2.  Long-term prognosis in patients continuing taking antithrombotics after peptic ulcer bleeding.

Authors:  Xi-Xu Wang; Bo Dong; Biao Hong; Yi-Qun Gong; Wei Wang; Jue Wang; Zhen-Yu Zhou; Wei-Jun Jiang
Journal:  World J Gastroenterol       Date:  2017-01-28       Impact factor: 5.742

3.  Changes in the Proportion of Gastrointestinal Emergency Endoscopy and Peptic Ulcer Disease During the COVID-19 Pandemic: A Local Retrospective Observational Study From Vietnam.

Authors:  Hang Viet Dao; Long Bao Hoang; Nha Ngoc Hoa Le; Trang Thi Thu Tran; Hung Manh Nguyen; Long Van Dao; Ngoan Tran Le
Journal:  Front Public Health       Date:  2022-02-18

4.  Cost-Effectiveness Analysis of the Helicobacter Pylori Screening Programme in an Asymptomatic Population in China.

Authors:  Tianyu Feng; Zhou Zheng; Jiaying Xu; Peng Cao; Shang Gao; Xihe Yu
Journal:  Int J Environ Res Public Health       Date:  2022-08-13       Impact factor: 4.614

5.  Comorbidity index for predicting mortality at 6 months after reperfusion therapy.

Authors:  Hyo Suk Nam; Young Dae Kim; Joonsang Yoo; Hyungjong Park; Byung Moon Kim; Oh Young Bang; Hyeon Chang Kim; Euna Han; Dong Joon Kim; Joonyung Heo; Minyoung Kim; Jin Kyo Choi; Kyung-Yul Lee; Hye Sun Lee; Dong Hoon Shin; Hye-Yeon Choi; Sung-Il Sohn; Jeong-Ho Hong; Jong Yun Lee; Jang-Hyun Baek; Gyu Sik Kim; Woo-Keun Seo; Jong-Won Chung; Seo Hyun Kim; Tae-Jin Song; Sang Won Han; Joong Hyun Park; Jinkwon Kim; Yo Han Jung; Han-Jin Cho; Seong Hwan Ahn; Sung Ik Lee; Kwon-Duk Seo; Ji Hoe Heo
Journal:  Sci Rep       Date:  2021-03-16       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.